Skip to content
Peptigraph home

How to Inject Melanotan II: Sites, Syringes and Steps

Where to inject Melanotan II, which syringe to use, how to read units and the hygiene steps that prevent infection.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureMelanocortin agonistUpdated
This is a general guide to subcutaneous injection, not a substitute for being shown by a nurse, pharmacist or doctor.

Injection sites

Most peptides are injected under the skin (subcutaneously), into the fatty layer rather than the muscle.

  • Belly: at least 2 inches (5 cm) away from the navel.
  • Front and outer thighs.
  • Back of the upper arms, if someone else can reach it.
  • Rotate sites each time and avoid skin that is bruised, scarred or irritated.

Syringe and needle

U-100 insulin syringes are marked in units: 100 units equal 1 mL, so 10 units is 0.1 mL. They come in 0.3, 0.5 and 1 mL sizes; a smaller syringe has finer marks and is easier to read for small doses. Needle length and gauge used for Melanotan II in studies: not reported in study abstracts (PubMed search, 2 Oct 2026).

How to read an insulin syringe

Step by step

  1. 1Wash your handsUse soap and water, and work on a clean surface.
  2. 2Check the vialLabel, lot and date present; solution clear with no particles. Mixing a powder vial first? Use sterile bacteriostatic water.
  3. 3Clean the vial top and the siteWipe both with an alcohol swab and let them dry.
  4. 4Draw the dosePull the plunger to the units mark for your dose, then tap out air bubbles and re-check the mark.
  5. 5InjectPinch a fold of skin, insert the needle at 45 to 90 degrees, push the plunger slowly and wait a few seconds before withdrawing.
  6. 6Dispose safelyPut the used syringe straight into a sharps container. Never reuse or share needles.
How to reconstitute a peptide vial

The only supervised injection data: a 3-volunteer pilot from the 1990s

The pilot study gave subcutaneous injections of melanotan II or saline daily on weekdays for 2 consecutive weeks to 3 normal male volunteers, in a single-blind alternating-day design.[7]

A later controlled human series on erection and sexual motivation reported that 12.9% of subjects had severe nausea at 0.025 mg/kg.[8]

What the reports of unsupervised injection describe

One case report describes systemic toxicity with sympathomimetic excess and rhabdomyolysis after use of Melanotan II.[9]

Another case report links an abdominal subcutaneous injection of melanotan to low-flow priapism, treated with cavernosal aspiration, irrigation and an intracavernosal phenylephrine injection.[10]

A third reports multiple new atypical naevi after melanotan injections; the authors point to a possible risk of stimulating dysplastic naevi or melanoma.[11]

A forensic laboratory analysing one vial labelled melanotan II measured a purity of 30%.[12]

FDA and registry text

Drugs@FDA returns no match for melanotan II, so no label supplies injection or storage instructions.[13]

FDA's safety-risk entry cites published case reports of serious adverse events including melanoma, posterior reversible encephalopathy syndrome, sympathomimetic toxidrome and priapism.[14]

Common questions

Where do you inject Melanotan II?

Under-the-skin (subcutaneous) injections are usually given in the belly, at least 2 inches from the navel, the front of the thighs or the back of the upper arms. Rotate sites each time.

What syringe is used for Melanotan II?

Vials are usually drawn with a U-100 insulin syringe, where 100 units equal 1 mL. Common sizes hold 0.3, 0.5 or 1 mL. Match the syringe to the dose so the mark is easy to read.

How often is Melanotan II injected?

The interval comes from the study or prescription, not from this guide. See the dosage page for what studies used.

Where do you inject melanotan 2?

The only supervised study did not name a body site in its abstract; one case report involved an abdominal subcutaneous injection.[10]

Is melanotan 2 safe to inject?

Nobody has established that it is safe. Reported effects include nausea and somnolence in the small studies, and rhabdomyolysis, priapism and new atypical naevi in case reports.[8]

Can you trust what is in a melanotan vial?

One forensic analysis of a labelled vial found 30% purity.[12]

More on Melanotan II

Sources

  1. 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
  2. 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
  3. 3PubMed search: "melanotan II"[tiab] OR "melanotan 2"[tiab] (198 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  4. 4PubMed search: ("melanotan II"[tiab] OR melanotan[tiab]) AND humans[mh] (82 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  5. 5PubMed search: ("melanotan II"[tiab] OR "melanotan 2"[tiab] OR melanotan[ti]) AND (case[tiab] OR naevi[tiab] OR nevi[tiab] OR melanoma[tiab] OR adverse[tiab] OR priapism[tiab] OR tanning[tiab] OR sunless[tiab]) AND humans[mh] (25 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  6. 6PubMed search: ("melanotan II"[tiab] OR "melanotan 2"[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (3 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  7. 7Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study.Life sciences · 1996PMID 8637402Accessed 2 Oct 2026
  8. 8Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II.International journal of impotence research · 2000PMID 11035391Accessed 2 Oct 2026
  9. 9Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.Clinical toxicology (Philadelphia, Pa.) · 2012PMID 23121206Accessed 2 Oct 2026
  10. 10Melanotan-induced priapism: a hard-earned tan.BMJ case reports · 2019PMID 30796078Accessed 2 Oct 2026
  11. 11Atypical melanocytic naevi following melanotan injection.Irish medical journal · 2013PMID 23914578Accessed 2 Oct 2026
  12. 12Barbie drug identification: Not a child's play.Journal of forensic sciences · 2024PMID 39302005Accessed 2 Oct 2026
  13. 13Drugs@FDA (openFDA) search: active ingredient "melanotan"U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  14. 14Official web pageOfficial web page · web page

Found an error? Report a correction.